Assertio Therapeutics's total assets for Q4 2025 were $266.97M, a decrease of -16.51% from the previous quarter. ASRT total liabilities were $173.02M for the fiscal quarter, a -19.14% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.